S

Shenzhen Salubris Pharmaceuticals Co Ltd
SZSE:002294

Watchlist Manager
Shenzhen Salubris Pharmaceuticals Co Ltd
SZSE:002294
Watchlist
Price: 31.74 CNY -1.64% Market Closed
Market Cap: 35.4B CNY
Have any thoughts about
Shenzhen Salubris Pharmaceuticals Co Ltd?
Write Note

Balance Sheet

Balance Sheet Decomposition
Shenzhen Salubris Pharmaceuticals Co Ltd

Current Assets 3.3B
Cash & Short-Term Investments 2.1B
Receivables 658m
Other Current Assets 532.1m
Non-Current Assets 6.3B
Long-Term Investments 1.8B
PP&E 1.4B
Intangibles 2.8B
Other Non-Current Assets 282.4m
Current Liabilities 1.2B
Accounts Payable 145.7m
Accrued Liabilities 584.9m
Short-Term Debt 35.3m
Other Current Liabilities 461.3m
Non-Current Liabilities 578.2m
Long-Term Debt 5m
Other Non-Current Liabilities 573.2m

Balance Sheet
Shenzhen Salubris Pharmaceuticals Co Ltd

Rotate your device to view
Balance Sheet
Currency: CNY
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
852
1 006
1 714
829
645
1 112
865
3 236
29
1 320
Cash
0
0
0
0
0
0
0
3 222
0
1 318
Cash Equivalents
851
1 005
1 714
829
645
1 112
865
14
29
2
Short-Term Investments
0
0
0
0
600
208
215
60
860
882
Total Receivables
1 307
1 439
1 512
1 502
1 581
1 243
585
660
590
579
Accounts Receivables
839
821
795
835
801
659
422
396
500
467
Other Receivables
468
618
717
667
780
584
163
265
90
111
Inventory
152
341
323
478
571
503
392
420
544
491
Other Current Assets
219
64
102
908
42
23
76
27
48
42
Total Current Assets
2 530
2 849
3 651
3 716
3 439
3 090
2 132
4 404
4 711
3 313
PP&E Net
872
1 037
1 199
1 267
1 398
1 535
1 677
1 692
1 506
1 457
PP&E Gross
872
1 037
1 199
1 267
1 398
1 535
1 677
1 692
1 506
1 457
Accumulated Depreciation
204
254
331
416
514
614
706
818
932
1 056
Intangible Assets
1 048
1 201
1 255
1 356
1 833
1 735
1 982
2 011
2 185
2 616
Goodwill
0
87
87
87
381
370
87
87
61
11
Note Receivable
0
0
0
0
0
0
0
0
0
0
Long-Term Investments
47
0
44
325
718
868
864
883
998
1 733
Other Long-Term Assets
119
213
299
114
137
136
177
167
295
266
Other Assets
0
87
87
87
381
370
87
87
61
11
Total Assets
4 616
N/A
5 387
+17%
6 534
+21%
6 864
+5%
7 905
+15%
7 733
-2%
6 919
-11%
9 244
+34%
9 755
+6%
9 397
-4%
Liabilities
Accounts Payable
105
170
77
91
118
144
223
188
186
156
Accrued Liabilities
120
127
157
170
228
354
329
487
558
491
Short-Term Debt
0
0
5
34
14
132
307
65
309
43
Current Portion of Long-Term Debt
0
0
15
15
15
60
10
7
11
11
Other Current Liabilities
568
302
715
262
300
88
228
266
539
114
Total Current Liabilities
793
599
969
573
675
778
1 097
1 013
1 604
815
Long-Term Debt
0
60
45
30
242
159
90
9
20
13
Deferred Income Tax
0
0
0
0
24
22
20
0
27
13
Minority Interest
9
106
100
106
210
177
83
12
36
36
Other Liabilities
35
32
61
103
93
109
120
176
128
501
Total Liabilities
837
N/A
797
-5%
1 174
+47%
811
-31%
1 244
+53%
1 244
0%
1 410
+13%
1 210
-14%
1 814
+50%
1 378
-24%
Equity
Common Stock
654
1 046
1 046
1 046
1 046
1 046
1 046
1 115
1 115
1 115
Retained Earnings
2 551
3 360
4 128
4 848
5 469
5 345
4 798
5 330
5 529
5 564
Additional Paid In Capital
574
182
182
161
144
144
0
1 930
1 866
1 900
Unrealized Security Profit/Loss
0
0
0
0
0
0
0
0
0
1
Treasury Stock
0
0
0
0
0
63
328
328
602
602
Other Equity
0
2
4
2
1
17
8
13
33
41
Total Equity
3 780
N/A
4 590
+21%
5 360
+17%
6 053
+13%
6 661
+10%
6 490
-3%
5 508
-15%
8 034
+46%
7 941
-1%
8 019
+1%
Total Liabilities & Equity
4 616
N/A
5 387
+17%
6 534
+21%
6 864
+5%
7 905
+15%
7 733
-2%
6 919
-11%
9 244
+34%
9 755
+6%
9 397
-4%
Shares Outstanding
Common Shares Outstanding
1 046
1 046
1 046
1 046
1 046
1 043
1 029
1 103
1 091
1 091

See Also

Discover More